(Yicai Global) Nov. 13 -- Bgi Genomics Co.[SHE:300676], a leader in China's gene sequencing (GS) sector, hit a record new high today that lifted its valuation to nearly CNY100 billion (USD 15.05 billion).

 After a static opening, the company's stock price maintained a steady climb in trading, reaching 10 percent higher to CNY242.61 per share this afternoon for a record high since the company listed on July 14.

 The price stayed at CNY242.61 until close, vaulting the company's valuation to CNY97.06 billion.

 Established in 1999, BGI Genomics supplies products and services covering the entire gene sequencing industry chain, including upstream sequencers and reagents and downstream GS services, and it enjoys clear advantages in relevant technologies.